Logo
Home
Company ProfileBoards & StaffsMemberships & PartnersAcademy of JournalismCareersBlog(EN)Contact Us
Our JournalsInstruction for AuthorsBrieflands PoliciesPublish My ResearchJournal Management SystemArticle Processing ChargesOpen Peer ReviewPublishing Services
Publish My Book
  1. Brieflands
  2. journals
  3. Shiraz E-Medical Journal
  4. Articles

  5. Effects of Cucurbita ficifolia Intake on Type 2 Diabetes: Review of Current Evidences
  6. Scopus by Title (Ref)

Shiraz E-Medical Journal

Home
Current IssueAll IssuesIn PressAccepted ManuscriptsSearch
Instructions
Journal InformationBoards and CommitteesIndexing and Listing SourcesJournal MetricsOpen Peer Review (OPR)Publication Ethics and Malpractice StatementReviewer and AE Registration FormAnnouncementSupportContact Us
APC
Authors GuideSubmit Manuscript

Scopus by Title (Ref)


1. Pumpkin Seed: Newer Perspectives

- Bashir K. , et al.

2. Protein identification and potential bioactive peptides from pumpkin (Cucurbita maxima) seeds

- Lin C.T. , et al.

3. Iranian Medicinal Plants in Diabetes Management: A Narrative Review of Traditional Herbal Remedies and Their Hypoglycemic Effects

- Afsharmanesh M.R. , et al.

4. Phenolic compounds and antioxidant activity in Cucurbita ficifolia fruits, an underrated fruit

- Moreno-Quiroga G. , et al.

5. The potential of pumpkin seeds as a functional food ingredient: A review: Biofunctional ingredients of pumpkin seeds

- Dotto J.M. , et al.

6. Cucumis sativus and cucurbita maxima extract attenuate diabetes-induced hepatic and pancreatic injury in a rat model

- Atta A.H. , et al.

7. Evaluation of the antihyperglycemic, antilipidemic and antioxidant potential of Cucurbita ficifolia in human type 2 diabetes

- Jain A. , et al.

8. A systematic review on indian floral biodiversity as eminent reserves for alternative treatment strategy of diabetes mellitus

- Priyanka , et al.

9. Plants with Anti-Diabetes Mellitus Properties

- Subramoniam A. , et al.

10. The efficacy and safety of a proprietary onion-pumpkin extract (OPtain120) on blood pressure: An open-label study

- Udani J. , et al.

HomeInstructionsAPC

Articles

  • Current Issue
  • All Issues
  • In Press
  • Accepted Manuscripts
  • Search

About Journal

  • Journal Information
  • Boards and Committees
  • Indexing and Listing Sources
  • Journal Metrics
  • Open Peer Review (OPR)
  • Publication Ethics and Malpractice Statement
  • Reviewer and AE Registration Form
  • Announcement
  • Support
  • Contact Us
Support
Submit a Ticket
BrieflandsBrieflands

Science, Technical, Medical Publisher, Since 2007

All rights reserved by Brieflands, 2026.

Powered by Neoscriber.